Therefore, the objective of this study was to evaluate the clinical inertia of insulin treatment intensification in a group of T2DM patients followed at a tertiary public Diabetes Center with limited pharmacologic armamentarium. This evidence concerns the gene INS and type 2 diabetes mellitus.